Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 285

The DOI matches its Crossref record; 169 of the 169 references it cites were found in a registry or an index.

Nitric oxide and the proliferation of vascular smooth muscle cells

Open access
Jeremy, J·1999·Cardiovascular Research

Abstract

Time for primary review 13 days. Vascular smooth muscle cell (VSMC) proliferation is an important component of vessel wall remodelling in response to injury, for example, after angioplasty or vein grafting, and during atherosclerosis formation. Endothelium-derived nitric oxide (NO) production is both a tonic and an induced regulator of blood vessel tone [1–3]. Its function is impaired by atherosclerosis and, more significantly, by atherogenic risk factors, including hypercholesterolaemia, homocysteinaemia, diabetes, smoking and high blood pressure, even before the appearance of overt atherosclerosis [4–6] Endothelial NO production is dysfunctional after balloon injury and in vein grafts at the time when VSMC proliferation and neointima formation is progressing [5,6]. It has been tempting, therefore, to propose a causal relationship between impaired NO production and increased VSMC proliferation. If so, this might explain, in part, the association between endothelial dysfunction and atherogenesis. The primary purpose of this review is to discuss critically the evidence to support such an hypothesis. We will also go on to consider the molecular mechanisms that might underlie the inhibitory effects of NO on VSMC proliferation, with the following important caveats. Firstly, any direct action of NO on an increase in VSMC numbers may be mediated at a variety of levels, for example, on the signal transduction pathways, on energy production or by promoting cell death. Secondly, in the more complex in vivo models, effects of NO on endothelial cells (ECs), platelets and inflammatory cells, rather than directly on VSMCs may be responsible for modulating VSMC proliferation. Thirdly, NO is highly unstable, with a half-life measured in seconds [2,7,8]. It reacts rapidly with oxygen species (O2, O2− and H2O2) to produce, nitrite, nitrate or the highly reactive species, peroxynitrite (ONOO) and with thiol groups to produce nitrosothiols [9]. Hence, the effects of NO and the pathophysiological influences on it may also be mediated indirectly, potentiated or inhibited through the availability of these oxygen species. Irrespective of the physiological role of NO in VSMC proliferation, a pharmacological effect of NO may still be exploited to reduce neointima formation and prevent adverse vessel-wall remodeling. We will therefore also consider the experience with this approach either in conventional or gene therapy. During atherogenesis, VSMCs are activated to a synthetic state, which allows them to proliferate and migrate to the intima and produce extracellular matrix [10,11]. This leads to neointima formation and the fibrous component of atherosclerosis [12,13]. Atherosclerosis is associated with a reduced endothelium-dependent vasodilatation, which has been ascribed to reduced NO formation [4,14]. Although endothelium-dependent responses are attenuated in aortic tissue from cholesterol-fed rabbits, total arterial NO production is actually increased [15]. This increased NO production is likely to be the result of the induction of inducible nitric oxide synthase (iNOS) in VSMCs [16–19]. Indeed, cholesterol loading of arterial VSMCs upregulates cytokine-induced NO formation [20]. Current evidence indicates that, despite this, the decrease in endothelium-dependent relaxation is a consequence of increased superoxide production, which quenches the increased levels of NO [21–23]. In a recent elegant study, Luoma et al. [24] found high expression of iNOS in VSMCs from both human and rabbit atherosclerotic lesions, which was co-localised with epitopes of oxidised low-density lipoprotein (LDL) and ONOO-modified proteins. These data consolidate the view that the local increase in levels of iNOS increases NO, which, together with increased superoxide, leads to the generation of ONOO and other nitrated oxygen species [9]. In animal models of neointima formation (arterial injury, vein grafts), where VSMC proliferation and migration are central events, NOS activity and NO release are also markedly altered. After balloon injury, there is inevitable endothelial loss, which ipso facto results in the loss of endothelial constitutive NOS (eNOS). Endothelial regrowth occurs rapidly [25], although several studies have indicated that the regrown endothelium in injured coronary arteries is dysfunctional [26,27]. This leads to agonist-selective impairment of endothelium-dependent vasodilatation, which suggests a defect in receptor–effector coupling. The loss of endothelial eNOS may be compensated for by increased iNOS expression [28]. In balloon-injured rat carotid arteries, iNOS expression is induced by interleukin 1-β (IL-1β) [29]. Medial and neointimal VSMCs are the main cell type expressing iNOS [30]. The situation is similar in vein grafts. For example, Cross et al. [31,32] and Ku et al. [33,34] found that porcine vein graft rings, pre-contracted with noradrenaline, failed to show endothelium-dependent relaxation in response to acetylcholine or

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0008-6363(99)00171-6

Cites

169 of 169 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 169 references

Cited by

See all 285

Metadata

Authors
Jeremy, J.
Venue
Cardiovascular Research
Published
1999-08-15
Volume
43
Issue
3
Pages
580-594
ISSN
0008-6363 (ISSN-L)
OpenAlex
W2137146936
Cited by
285
References
169
FWCI
4.50
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nitric oxide and the proliferation of vascular smooth muscle cells. https://app.cochat.ai/papers/10.1016/s0008-6363(99)00171-6
The paper
Jeremy, J. (1999). Nitric oxide and the proliferation of vascular smooth muscle cells. Cardiovascular Research. https://doi.org/10.1016/s0008-6363(99)00171-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.